已收盘 07-02 16:00:00 美东时间
-45.490
-11.07%
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
BMO Capital started coverage of MKS (MKSI) with an Outperform rating and a $453 price target, citing broad chip equipment exposure and AI-data center tailwinds. Shares of chip equipment maker MKS clim...
06-30 20:52
KeyBanc周一重申应用材料及MKS仪器“增持”评级,并将应用材料的目标价由550美元上调至750美元、将MKS仪器的目标价由360美元上调至475美元。
06-30 14:35
今日重点评级关注:Evercore ISI集团:维持ProQR Therapeutics"跑赢大市"评级,目标价从5美元升至6美元;摩根士丹利:维持霍尼韦尔"标配"评级,目标价从245美元升至490美元
06-30 10:14
MKSI盘中大涨6.71%,逼近415美元关键技术关口,当前股价处于60日波动区间的96.5百分位,但上涨伴随参与度不足问题,相对成交量仅为20日均值的0.6...
06-30 00:31
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for Applied Materials Inc (NASDAQ:AMAT) from $550 to $750. Keybanc analyst Ste...
06-29 21:05
核心事件:MKS仪器(MKSI)盘中出现大幅反转,从高点401.05美元滑落至385美元,最终收跌4.57%报391.555美元,抹掉盘中多数涨幅,本次下跌无公...
06-27 00:57
今日重点评级关注:摩根士丹利:维持杜邦"标配"评级,目标价从52美元升至156美元;蒙特利尔银行:维持Taysha Gene Therapies"跑赢大市"评级,目标价从10美元升至14美元
06-24 14:08
Investors Should Know: The AI chip supply chain is facing a critical bottleneck at the manufacturing and testing layer, where optical interconnect scaling and silicon photonics capacity are emerging a...
06-24 02:31
B of A Securities analyst Vivek Arya maintains MKS (NASDAQ:MKSI) with a Buy and raises the price target from $380 to $500.
06-23 20:47